MYCN (N-MYC) Gene Amplication, FFPE Tissue
Guaranteed Safe Checkout
MYCN (N-MYC) Gene Amplication, FFPE Tissue
Assess cancer prognosis with the MYCN (N-MYC) Gene Amplification, FFPE Tissue test at Lucid Medical Diagnostics. This advanced molecular genetic test detects MYCN (N-MYC) gene amplification in FFPE tissue samples, supporting the diagnosis and risk assessment of neuroblastoma and other MYCN-associated cancers. Our specialized cancer genetic testing, molecular diagnostics, and oncology biomarker analysis provide accurate, reliable, and timely results to guide personalized treatment decisions. Trust Lucid Medical Diagnostics for state-of-the-art laboratory technology and expert diagnostic services dedicated to precision cancer care.
Home Sample Collection Available
Get Reports
